Jiménez-Aguilar Patricia, López-Cortés Luis Eduardo, Rodríguez-Baño Jesús
Unidad Clínica de Enfermedades Infecciosas, Hospital Universitario Puerto Real, Puerto Real, Cádiz, Spain.
Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen Macarena, Instituto de Biomedicina de Sevilla (IBiS), Sevilla, Spain.
Ther Adv Infect Dis. 2019 Dec 6;6:2049936119893576. doi: 10.1177/2049936119893576. eCollection 2019 Jan-Dec.
Bacteraemia or bloodstream infections (BSI) are associated with much morbidity and mortality. Management of patients with bacteraemia is complex, and the increase in immunosuppressed patients and multidrug-resistant organisms poses additional challenges. The objective of this review is to assess the available published information about the impact of different aspects of management on the outcome of patients with BSI, and, specifically, the importance of infectious diseases specialists (IDS) consultation. The impact of management by IDS on different aspects, including interpretation of newer rapid techniques, early evaluation and treatment, and follow up, are reviewed. Overall, the available data suggest that IDS intervention improves the management and outcome of patients with BSI, either through consultation or structured unsolicited interventions in the context of multidisciplinary bacteraemia programmes.
菌血症或血流感染(BSI)与较高的发病率和死亡率相关。菌血症患者的管理很复杂,免疫抑制患者和多重耐药菌的增加带来了额外的挑战。本综述的目的是评估已发表的关于管理的不同方面对BSI患者结局影响的可用信息,特别是传染病专科医生(IDS)会诊的重要性。综述了IDS管理在不同方面的影响,包括对更新的快速技术的解读、早期评估和治疗以及随访。总体而言,现有数据表明,IDS干预通过会诊或在多学科菌血症项目背景下进行的结构化主动干预,改善了BSI患者的管理和结局。